Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.

Source:http://linkedlifedata.com/resource/pubmed/id/10929020

Download in:

View as

General Info

PMID
10929020